Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
series B
Manufacturing
Phlow reaps $36M in series B fundraising to boost CDMO program
Phlow reeled in $36 million in series B fundraising to help expand its contract manufacturing program.
Joseph Keenan
Apr 6, 2023 9:35am
SaNOtize bags $24M to fund phase 3 trial of COVID-19 nasal spray
Aug 30, 2022 9:55am
Ori Biotech reaps $100M in series B round of fundraising
Jan 18, 2022 9:10am
Gene therapy 'development engine' nabs $120M to amp up CDMO work
Apr 29, 2021 8:00am
China’s CMAB Biopharma captures $34M in series B funding
Apr 5, 2018 8:50am
FiercePharmaAsia—Teva, Lupin, EOC and more
Nov 10, 2017 10:13am
